.

.

32940

Vetera 6XP Vaccine, Killed Virus, 10mL

Boehringer Ingelheim - Encephalomyelitis-Rhinopneumonitis-Influenza Vaccine; Influenza (Clade 1 and Clade 2), Herpes (EHV-1 and EHV-4) and Eastern, Western & Venezuelan Encephalomyelitis killed virus, Tetanus Toxoid

$352.59
Quantity

Encephalomyelitis-Rhinopneumonitis-Influenza Vaccine; Influenza (Clade 1 and Clade 2), Herpes (EHV-1 and EHV-4) and Eastern, Western & Venezuelan Encephalomyelitis killed virus, Tetanus Toxoid. 

Species: Horses

FEATURES / BENEFITS

Safe for use in horses as young as 4 months of age, including pregnant mares

Protects against EIV, EHV (EHV-1 and EHV-4), VEE, EEE, WEE, and Tetanus in 1 mL dose

At least 6 month duration of immunity against equine influenza (Ohio/03)

Ohio/03 (Clade 1), Kentucky/95, and Richmond/07 (Clade 2) equine influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza

Unique purification process and adjuvant formulation minimizes non-relevant protein presented to the immune system

Available in single dose pre-filled syringes or color-coded 10 dose vials

SPECIFICATIONS

Provides 6-month duration of immunity against equine influenza (Ohio/03).

Store at 35 to 45 °F (2 to 7 °C); protect from freezing.

Do not vaccinate within 21 days before slaughter.

Use entire contents when first opened.

Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

INSTRUCTIONS

Shake well before use.  Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

32940

Specific References

related products